Leukoencephalopathy with brainstem and spinal cord involvement and elevated brain lactate diagnosis is based on its highly characteristic pattern of abnormalities observed by magnetic resonance imaging and spectroscopy. Clinically, affected patients develop slowly progressive cerebellar ataxia, spasticity, and dorsal column dysfunction, sometimes with a mild cognitive deficit or decline. In 2007, the pathophysiology of this disorder was elucidated with the discovery of mutations in the DARS2 gene, which encodes mitochondrial aspartyl-tRNA synthetase, in affected individuals. Here, the authors present a case of leukoencephalopathy with brainstem and spinal cord involvement with normal brain lactate, in which genetic analysis revealed a new mutation in the DARS2 gene not previously described.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/0883073810370897 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Imaging in atypical van der knaap disease with subependymal nodular heterotopia: A case report.
Radiol Case Rep
February 2025
Junior Resident, Department of Radiodiagnosis, Kempegowda Institute of Medical Sciences Hospital and Research Centre, Rajiv Gandhi University of Health Sciences, Bangalore, 560004, Karnataka, India.
Here, we discuss a rare and to our knowledge, the first case of an atypical Van der Knaap's disease in a 6-year-old boy who presented with motor difficulties, developmental delay, cognitive impairment, seizures. The objective of this report is to highlight its unusual findings on MRI including internal capsule, brainstem, cerebellum involvement; subependymal nodular heterotopia, subependymal cysts, cortical laminar necrosis along with typical findings of megalencephalic leukoencephalopathy and subcortical cysts. The study also underscores the clinical implications of this complex pathology, with emphasis on comprehensive neuroradiological evaluation for atypical presentations to guide better diagnostic and management outcomes.
View Article and Find Full Text PDFVCAM-1 Mesenchymal Stem/Stromal Cells Reveal Preferable Efficacy Upon an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis Over the VCAM-1 Counterpart.
Neurochem Res
November 2024
Department of Neurology, The Second Hospital of Shandong University, 247 Beiyuan Road, Jinan, China.
Despite the considerable progress in mesenchymal stem/stromal cells (MSCs)-based novel intervention of multiple sclerosis (MS), yet the disease-modifying effect of VCAM-1 MSCs and novel VCAM-1 counterpart is largely obscure. In this study, we took advantage of the EAE mouse model and VCAM-1 human umbilical cord-derived MSCs (hUC-MSCs) for the evaluation of the therapeutic effect of systematic MSCs infusion. On the one hand, we compared the protective effect of VCAM-1 and VCAM-1 hUC-MSCs against the clinical symptoms, demyelination, active glia cells and neuroinflammation in EAE mice by conducting multifaceted detections upon spinal cord and brain tissues.
View Article and Find Full Text PDFPosterior reversible encephalopathy syndrome (PRES) is a reversible clinico-radiological condition primarily affecting the occipito-parietal regions. Thalami, brainstem, and cerebellar involvement with posterior fossa oedema are rare manifestations of this condition. We present the case of a 66-year-old male with a travel history to Thailand who was found collapsed on the floor two weeks after his return.
View Article and Find Full Text PDFInfantile Krabbe disease (0-12 months), progression, and recommended endpoints for clinical trials.
Ann Clin Transl Neurol
December 2024
Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Article Synopsis
- Krabbe disease is caused by a deficiency in galactocerebrosidase, leading to severe neurodegeneration, particularly in infants, and the study aimed to track the disease's progression and the impact of hematopoietic stem cell transplantation (HSCT).* -
- The research involved 137 infants with Krabbe disease over 22 years, comparing outcomes between those who underwent HSCT and those who did not, revealing that early symptoms could include irritability and developmental delays, and overall survival rates varied significantly based on treatment.* -
- Results indicated that while HSCT improved galactocerebrosidase levels and extended lifespan, it couldn't halt the progression of nerve damage, emphasizing the critical need for
CRISPR-edited human ES-derived oligodendrocyte progenitor cells improve remyelination in rodents.
Nat Commun
October 2024
Centre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.
Article Synopsis
- Multiple Sclerosis (MS) causes inflammation that leads to damage in the brain and spinal cord, resulting in disability, and current treatment options for remyelination are limited.
- Researchers have developed genetically edited oligodendrocyte progenitor cells (OPCs) that can better migrate and repair damage in chronic MS lesions, in response to obstacles that normally hinder their performance.
- In rodent models, these edited OPCs showed improved remyelination capabilities regardless of the age of the host, suggesting potential new therapeutic strategies for treating progressive MS in humans.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!